phase readout
saveNCT07231679: A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
RECRUITINGupdated 50m ago
community read0 votes
Sponsor: Ingenia Therapeutics INC. Phase: PHASE1. Conditions: Healthy Volunteers, Chronic Kidney Disease
view source ↗
comments(0)
5-min edit window · permanent after that